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Background
Many patients with post-traumatic stress disorder (PTSD)
experience dissociative symptoms. The question of whether
these dissociative symptoms negatively influence the effective-
ness of psychotherapy for PTSD is unresolved.
Aims
To determine the influence of dissociative symptoms on psy-
chotherapy outcome in PTSD.
Method
We conducted a systematic search in Cochrane, Embase,
PILOTS, PsycINFO, PubMed and Web of Science for relevant
clinical trials. A random-effects meta-analysis examined the
impact of dissociation on psychotherapy outcome in PTSD (pre-
registered at Prospero CRD42018086575).
Results
Twenty-one trials (of which nine were randomised controlled trials)
with 1714 patients were included. Pre-treatment dissociation was
not related to treatment effectiveness in patients with PTSD
(Pearson’s correlation coefficient 0.04, 95% CI −0.04 to 0.13).
Between-study heterogeneity was high but was not explained by
moderators such as trauma focus of the psychotherapy or risk of
bias score. There was no indication for publication bias.
Conclusions
We found no evidence that dissociation moderates the effect-
iveness of psychotherapy for PTSD. The quality of some of the
included studies was relatively low, emphasising the need for
high-quality clinical trials in patients with PTSD. The results sug-
gest that pre-treatment dissociation does not determine psy-
chotherapy outcome in PTSD.
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Background
In the DSM-5, a dissociative subtype was added to the classification
criteria of post-traumatic stress disorder (PTSD). This subtype
describes patients who meet diagnostic criteria for PTSD, and add-
itionally have persistent or recurrent symptoms of depersonalisa-
tion (i.e. experience of unreality or detachment from one’s
thoughts, feelings, sensations, body or actions, for example, unreal
or absent self) and derealisation (i.e. experience of unreality or
detachment from one’s surroundings, for example dreamlike or
foggy1). The addition of a dissociative subtype to the DSM-5 was
based on multiple sources of evidence, pertaining to factor analyses,
brain activation patterns and response to treatment.2
Approximately 14% of the patients with PTSD meet criteria for
the dissociative subtype.3 Although this subtype was only recently
added to the DSM-5, research on dissociative symptoms in the
context of trauma dates back to the nineteenth century.4 Several
studies have shown that PTSD is associated with high levels of dis-
sociation, both compared with non-clinical samples and patients
with other psychiatric disorders.5–8 Additionally, several studies
have shown that dissociation is strongly related to the other PTSD
symptoms and that these clusters wax and wane together, also in
response to treatments.9–13
A review of brain-imaging studies has shown that dissociative
symptoms/states are related to activation of brain areas related
to neurological overmodulation of affect.14 This overmodulation
of affect could, among others, reduce emotional engagement
with the trauma memory, which is considered to be a relevant
factor in understanding the effectiveness of current psychother-
apies for PTSD.15 This lack of engagement may be specifically
relevant for exposure-based psychotherapy as fear activation is
thought to be a crucial mechanism underlying the treatment
effect.14,16–20
Aims
Currently, there is no consensus about (a) whether patients with
PTSD and who dissociate benefit as much from psychotherapy as
patients with PTSD who do not dissociate and (b) whether some
forms of psychotherapy are particularly ineffective for patients
with PTSD and dissociation. Some authors have suggested that
treatment programmes need to be tailored for patients with PTSD
who have dissociative symptoms, because, as a result of their
limited emotion regulation capacities, trauma-focused treatments
might even lead to an increase in PTSD symptoms, overall distress
and functional impairment.14 Others have argued that there is no
evidence for an impeding effect of dissociation on the effectiveness
of psychotherapy for PTSD.21 The aim of this study is to provide
more clarity to this ongoing debate by quantifying the moderating
effect of dissociation on the effectiveness of psychotherapy for
PTSD in a meta-analysis.
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Method
This project was pre-registered at Prospero (https://www.crd.york.
ac.uk/prospero/display_record.php?RecordID=86575).
Search strategies
We conducted systematic searches in the following databases up to
the 28 August 2018: Cochrane trials register, Embase, PILOTS,
PsycINFO, PubMed and Web of Science. Relevant results during
the search of review articles, book chapters and studies were
searched for further studies and additionally, key authors and
research groups were contacted via email to request any data rele-
vant to the study. Search terms were based on (MeSH) terms for
PTSD [AND] dissociation [AND] psychotherapy and were
adapted to every specific search engine to ensure inclusion of all
relevant studies. The search includes the following terms for:
(a) PTSD: Posttrauma* Stress Disorde*, Post-Trauma* Stress
Disorde*, Post Trauma* Stress Disorde*, DESNOS, CA-
PTSD, C-PTSD, PTSD;
(b) dissociation:Dissocia*Depersonali*Derealization*Derealisation*
Fugue* Psychogenic amnesia, and
(c) psychological treatment: Psychotherap*, Therap*, Posttraumatic
Growth, Interven*, Treat*, Exposure, EMDR, CBT, STAIR,
Recover*.
We manually searched for studies in prior meta-analyses and
reviews to ensure that no studies were missed in the systematic
search. We de-duplicated data of the search following the protocol
of Bramer and colleagues.22
Inclusion criteria
The criteria for individual papers for inclusion were: (a) inclusion of
patients who were 18 years of age and older; (b) assessment of PTSD
according to the DSM-5, DSM-IV, DSM-III-R or DSM-III criteria;
(c) evaluation of psychotherapy with PTSD symptom severity as
main outcome; (d) inclusion of validated self-reportmeasures or struc-
tured clinical interviews to assess both PTSD symptom severity and
dissociation severity; (e) assessment of PTSD symptom severity at
pre- and post-treatment; (f) assessment of pre-treatment dissociation
severity; (g) inclusion of at least ten participants per treatment condi-
tion which is analysed; (h) published in a peer-reviewed journal; and
(i) written in English, Dutch, German, Italian, Spanish or French.
Data extraction and risk of bias assessment
Eligible studies were screened twice and data were extracted twice by
two independent screeners. All discrepancies were resolved through
discussion and consensus. Risk of bias of the studies was assessed
independently by two of the authors using the Cochrane risk of
bias tool, which resulted in a methodological score for each study
included.23 The Cochrane scale assesses sources of bias including
selection bias, detection bias and attrition bias. We added two
items to this measure about: (a) the type of the PTSD measurement
(clinical interview versus self-report); and (b) treatment integrity
(whether the original article reported on treatment integrity, yes
versus no). Consequently, the adapted Cochrane scale consisted of
eight items (see supplementary Table 1 available at https://doi.org/
10.1192/bjo.2020.30). Two raters scored each item, and their
scores were summed into a risk of bias score (range 0–16; with
higher scores indicating higher risk of bias). The risk of bias score
was used as a moderator. High bias scores were not considered an
exclusion criterion for further analysis.
Potential moderators
To investigate potential moderators of the effect of dissociation on
psychotherapy outcome, we coded several study characteristics:
(a) completely trauma-focused treatment (yes versus no); (b) rando-
mised controlled trial (yes versus no); (c) sample size (continuous
variable); and (d) risk of bias score (continuous variable). The
potential moderators were independently coded by two authors
and differences were resolved through discussion and consensus.
We compared treatments that were exclusively trauma focused
versus those that were not. As dissociation is thought to be because
of failing emotion regulation capacities, exposure to traumaticmemor-
ies would result in emotional overmodulation and consequently
impede fear activation and emotional learning. This may prevent the
therapeutic effect of exposure, unless emotion regulation or other
coping skills are also addressed.14 The treatment was coded as
trauma focused if it comprised only evidence-based trauma-focused
treatment strategies as described in the manuscript (i.e. prolonged
exposure, cognitive processing therapy or eye movement desensitisa-
tion and reprocessing). Treatments that also comprised other treat-
ment components (i.e. physical activity or stabilisation) or treatments
that did not include trauma-focused treatment strategies were coded
as not exclusively trauma focused. If a trial included both types of treat-
ments, we extracted the effect size for the two conditions separately
for this moderation analysis (see supplementary Fig. 1 for details).
Statistical analysis
The R package meta was used for all analyses.24 The effect of dissoci-
ation on PTSD treatment was determined using pooled effect sizes
of the moderating effect of dissociationmeasured with the Pearson’s
correlation coefficient (r) between pre-treatment dissociation and
change in PTSD symptoms from pre- to post-treatment (post-treat-
ment minus pre-treatment PTSD symptom severity score). A posi-
tive correlation would indicate a negative relationship between
dissociation and treatment effectiveness, whereas a negative correl-
ation would indicate a positive effect of dissociation on treatment
effectiveness. Where needed, we calculated the reported effect size
from the data provided into r as common metric.
In cases where we were unable to calculate the effect size from
the publication, we contacted the researchers for additional data.
We contacted 38 researchers of whom 27 responded. Twelve of
these researchers did not provide the data for various reasons (for
example no access to data, no time to get data, not willing to
share data). Fifteen researchers provided the requested data.
Twelve of these studies met the inclusion criteria and were included
in the meta-analysis.
We used a random-effects model that allows heterogeneity
between studies (assessed with the Q index) and performed a rank
test to detect asymmetry in the funnel plot, which is an indication
of publication bias. If we had any indications of publication bias
either by the rank tests or by visual inspection, we used a trim and
fill procedure to correct for bias because of missing studies. In case
of a statistically significant main finding of dissociation on treatment
effectiveness, we performed the fail-safe tests of Rosenthal and Orwin
to assess the robustness of the results.We conductedmoderation ana-
lyses with a meta-regression approach by fitting mixed-effect models
including potential treatment moderators to test for differences in the
effect size associated with characteristics of the studies.
Results
Selection and inclusion of studies
The systematic searches yielded a total of 3563 papers (2549 after
removal of duplicates). Of these 2549 papers, 2437 were excluded
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based on title and abstract as they did not meet inclusion criteria. In
total, 112 full-text papers were retrieved of which 91 were excluded
because they did not meet the inclusion criteria (see Fig. 1 for
details). The remaining 21 articles were included in this meta-analysis.
Note that none of the included studies used severe levels of dissociation
or diagnosis of dissociative (identity) disorder as exclusion criterion.
Characteristics of included studies
The 21 included studies contained a total of 1714 patients from 9
RCTs and 12 uncontrolled clinical trials or treatment cohort
studies.8,9,13,25–42 Table 1 shows the study characteristics and poten-
tial moderator variables (see supplementary Table 2 for more study
details).
Risk of bias score
The overall risk of bias of the included studies was modest (mean
6.6, s.d. = 2.94). Table 2 lists item and total scores for the risk of
bias scores for each of the included studies. Agreement between
two independent assessors regarding risk of bias of individual
studies was high (Cohen’s kappa = 0.81, s.e. = 0.04, P < 0.001).
Effect of dissociation on PTSD treatment
Figure 2 depicts the main results of the meta-analysis. The pooled
correlation between pre-treatment dissociation and decrease in
PTSD symptoms during treatment was 0.04 (95% CI −0.04 to
0.13, P = 0.32). The heterogeneity between studies was moderately
high: I² = 68.90, P < 0.001. Visual inspection of the funnel plot did
not indicate asymmetry in any direction (Fig. 3), which was con-
firmed by Kendall’s tau based on the rank correlation (P = 0.46)
and by Eggers’ test (P = 0.25). The funnel plot shows two potential
outliers: Harned et al (2014)32 (positive effect of dissociation) and
Abramowitz & Lichtenberg (2016)25 (negative effect). The study
sample of Harned et al (2014)32 was very small and the drop-out
was high. The study of Abramowitz & Lichtenberg (2016)25 was
an open study with a relatively small sample size. Therefore, both
studies may have yielded an effect size that is not so reliable.
Effect of potential moderators of the effect of
dissociation on PTSD treatment outcome
Table 3 shows the results of the moderation analyses. We did not
find that a higher risk of bias resulted in a larger effect of dissoci-
ation, although this effect was borderline significant (slope
r = 0.03, 95% CI −0.002 to 0.06, P = 0.07). In addition, we found
no difference in the effect of dissociation on the effectiveness
of completely trauma-focused treatments compared with non-
trauma-focused/multicomponent treatments (P = 0.76). Similarly,
we did not find that the effect of dissociation was different for ran-
domised controlled trials compared with non-randomised studies
(P = 0.18), nor did we find an effect of sample size (P = 0.38).
Records identified through
database searching 























Additional records identified 
through other sources 
(n = 2)
Records after duplicates removed 
(n = 2549) 
Records screened 
(n = 2549) 
Records excluded based on title
and abstract (n = 2437)  
Full-text articles assessed
for eligibility
(n = 112) 
Full-text articles excluded, with reasons 
(n = 91) 
- No data effect dissociation       (n = 20) 
- Duplicate study sample       (n = 12) 
- No clinical study or article       (n = 14) 
- No measurement dissociation       (n = 11) 
- No PTSD treatment         (n =   7) 
- Sample PTSD < 10         (n =   6) 
- No PTSD measurement pre–post   (n =   6) 
- Article/data not found         (n =   6) 
- Exclusion of severe dissociation    (n =   4) 
- No diagnosis PTSD         (n =   4) 
- No patients > 18         (n =   1) 




(n = 21)  
Fig. 1 Flow chart of inclusion of studies.
PTSD, post-traumatic stress disorder.
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Table 1 Selected characteristics of studies examining the effect of dissociation on post-traumatic stress disorder (PTSD) psychotherapy treatment outcome










Abramowitz & Lichtenberg (2010)25 Hypnotherapeutic olfactory
conditioning
NR 0 41.2 (12.2) IES-R; DSM-IV DES No No RCT 36 11.0
Bae et al (2016)26 EMDR 1.27 completers 59 34.9 (11.6) CAPS; DSM-IV CAPS subtype items
+ decreased
awareness
Yes No RCT 60 8.0
Cloitre et al (2012)27 Stair/NST; Support/NST;
Stair/support
1.97 ITT 100 36.4 (9.40) CAPS; DSM-IV TSI-DIS averaged
score
No RCT 75 3.0
Gantt et al (2007)28,
a
Art, hypnosis, video therapy NR 77 38 (14) IES; DSM-IV DES No No RCT 53 11.0
Haagen et al (2018)29 EMDR, NET, other interventions 0.36 completers 3.1 39.8 (10.1) IES-R; DSM-IV DES No No RCT 64 8.0
Hagenaars et al (2010)30 Prolonged exposure 3.07 completers 83 35.75 (11.74) CAPS; DSM-IV DES Yes No RCT 36 4.0
Halvorsen et al (2014)31 NET + TAU 0.95 completers 31 35.55 (11.05) CAPS; DSM-IV CAPS subtype items TAU: No; NET: Yes RCT 81 5.0
Harned et al (2014)32 DBT + DBT-prolonged exposure 1.8 ITT 100 32.6 (12.0) PSS; DSM-IV DES No RCT 12 3.0
Kleindienst et al (2016)33 DBT-PTSD NR 100 37.3 (10.5) CAPS; DSM-IV DES No RCT 24 4.5
Kratzer et al (2019)8 EMDR + emotional regulation
focused group
1.81 completers 88 47.9 (10.5) IES-R; DSM-IV DES No No RCT 150 8.5
Lampe et al (2014)34,
a
PITT + psychodynamic group NR. 100 40.72 (10.0) IES; DSM-IV DES No No RCT 88 9.0
Lynch et al (2008)9,
a
NR NR 83 36 (9.99) PDS; DSM-IV DES No No RCT 127 8.5
Murphy & Busuttil (2015)35 Group + individual CBT NR 1 NR PSS; DSM-IV DES No No RCT 244 11.0
Pabst et al (2014)36,
a
NET; TBE 0.95 completers 100 29.91 (10.11) PDS; DSM-IV DES TBE: No; NET: Yes RCT 36 3.0
Resick et al (2012)37 CPT; CPT-C; WTA 1.68 ITT 100 35.4 (12.4) CAPS; DSM-IV TSI-DIS Yes RCT 117 3.0
Steele et al (2018)38 Treatment programme 0.70 completers 29 42.94 (11.63) Mississippi scale for PTSD; DSM-III DES No No RCT 62 10.0
Steuwe et al (2016)39 NET + SIC 0.70 ITT 90.9 34.9 (9.71) PDS; DSM-IV DES No No RCT 11 7.5
van Emmerik et al (2008)40,
a
CBT; SWT 0.79 ITT 65 40.87 (11.97) IES; DSM-IV DES Yes RCT 50 6.5
Van Minnen et al (2016)41 Prolonged exposure; EMDR 1.67 completers 54 41.2 (10.5) CAPS; DSM-IV CAPS subtype items Yes RCT 82 6.0





Zoet et al (2018)13 EMDR + prolonged exposure + sport 2.03 completers 70 38.16 (10.90) CAPS; DSM-IV CAPS subtype items No No RCT 169 5.0
NR, not reported; IES, Impact of Events Scale; DES, Dissociative Experiences Scale; DES-T, DES-taxon; RCT, randomised controlled trial; EMDR, eye movement desensitisation and reprocessing; CAPS, Clinician-Administered PTSD scale; Stair: skills training in affective and
interpersonal regulation; NST, narrative story telling; ITT, intention to treat; TSI-DIS: Trauma Symptom Inventory-Dissociation; NET, narrative exposure therapy; TAU, treatment as usual; DBT, dialectical behaviour therapy; DBT-PTSD, DBT for PTSD; PSS, PTSD Symptom Scale;
PITT, psychodynamic imaginative trauma therapy; PDS: Post-Traumatic Stress Diagnostic Scale; CBT, cognitive– behavioural therapy; TBE, treatment by experts of borderline disorder; CPT, cognitive processing therapy; CPT-C: cognitive therapy only; WTA, written trauma
accounts only; SIC, standard inpatient care; SWT: structured writing therapy; PCT, present-centred therapy.
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Table 2 Risk of bias scores of included studies with higher scores indicating a higher risk of bias.
Item
Study 1 2 3 4 5 6 7 8 Total
Abramowitz & Lichtenberg (2010)25 1\1 1\1 1\1 1\1 2\2 2\2 2\2 1\1 11.0
Bae et al (2016)26 1\1 1\1 0\0 1\1 0\0 2\2 2\2 1\1 8.0
Cloitre et al (2012)27 0\0 0\1 2\2 0\0 0\0 0\0 0\0 0\1 3.0
Gantt et al (2007)28 1\1 1\1 1\1 1\1 2\2 2\2 2\2 1\1 11.0
Haagen et al (2018)29 1\1 1\1 0\0 1\1 0\0 2\2 2\2 1\1 8.0
Hagenaars et al (2010)30 1\1 1\1 0\0 1\1 0\0 0\0 0\0 1\1 4.0
Halvorsen et al (2014)31 1\1 1\1 2\1 0\0 0\0 0\0 2\2 0\1 5.0
Harned et al (2014)32 1\1 1\1 1\1 0\0 0\0 0\0 0\0 1\1 3.0
Kleindienst et al (2016)33 1\1 0\0 0\0 0\0 2\2 0\0 2\2 0\1 4.5
Kratzer et al (2019)8 1\1 1\1 1\1 1\1 0\0 2\2 2\1 1\1 8.5
Lampe et al (2014)34 1\1 1\1 1\1 1\1 0\0 2\2 2\2 1\1 9.0
Lynch et al (2008)9 1\1 1\1 1\1 1\1 0\0 2\2 2\1 1\1 8.5
Murphy & Busuttil (2015)35 1\1 1\1 2\2 2\2 2\2 0\0 2\2 1\1 11.0
Pabst et al (2014)36 1\1 1\1 1\1 1\1 0\0 2\1 0\0 0\1 3.0
Resick et al (2012)37 0\1 0\0 2\2 0\0 0\0 0\0 0\0 0\1 3.0
Steele et al (2018)38 1\1 1\1 1\1 1\1 2\2 2\1 2\1 1\1 10.0
Steuwe et al (2016)39 1\1 1\1 1\1 0\0 0\0 2\2 2\1 1\1 7.5
van Emmerik et al (2008)40 0\0 1\1 1\1 0\0 0\0 2\2 2\2 0\1 6.5
Van Minnen et al (2016)41 0\1 0\1 2\2 0\0 2\2 0\1 0\0 0\1 6.0
Wolf et al (2016)42 1\1 1\1 0\0 0\0 0\0 0\0 0\0 0\1 2.5
Zoet et al (2018)13 1\1 1\1 0\0 0\0 0\0 0\0 2\2 1\1 5.0
Item 1, random sequence generation; item 2, allocation concealment; item 3, selective reporting; item 4, masking of outcome assessment; item 5, incomplete outcome data; item 6, out-
come measurement type; item 7, treatment integrity; item 8, other bias.
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Positive effect         Negative effect
Statistics for each study Correlation and 95% CI
Fig. 2 Pearson’s Correlation coefficient (r) between baseline dissociation and change in post-traumatic stress disorder symptoms from pre- to
post-treatment.
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To explore the effect of risk of bias on the results, we performed
a post hoc analysis including only studies with a low–moderate risk
of bias (i.e. risk of bias score≤ 8 (n = 14)). The correlation between
pre-treatment dissociation and decrease in PTSD symptoms during
treatment for higher-quality studies was −0.01 (95% CI −0.13 to




We found no evidence for a moderating effect of dissociation on
psychotherapy outcome in patients with PTSD. Furthermore, dif-
ferences between studies in the effect size of dissociation on treat-
ment outcome were not explained by study characteristics. We
conclude that comorbid dissociative symptoms do not reduce the
effectiveness of psychotherapy in patients with PTSD. Although
we did not specifically examine the dissociative subtype of PTSD,
the present findings suggest that this subtype may not be associated
with worse treatment outcomes as was suggested by the introduc-
tion of this subtype in the DSM-5.
Most included studies found non-significant effects of dissoci-
ation on the treatment outcome, which corresponds to the null
finding of this meta-analysis. The results from the studies reported
in this meta-analysis may differ from the conclusion from the indi-
vidual papers. Some of these studies were hampered by methodo-
logical limitations, including incorrect moderation analyses. We
assessed dissociation as a treatment moderator. Some individual
studies, however, did not test moderation, but reported the associ-
ation between dissociation and post-treatment PTSD severity.
We were able to include a relatively large number of recently
published clinical trials. The addition of the dissociative subtype
to the DSM-5 seems to have increased awareness and research
into dissociation. We found a moderately high heterogeneity
among studies, indicating that the effect of dissociation varied
because of systematic differences rather than chance. Despite this
variation, the pooled effect size allows a uniform conclusion since
the error bars (95% CI) of the effect sizes of most studies include
the pooled effect size.43 Moreover, we did not find indications for
publication bias.
We examined whether the following study characteristics
explained the heterogeneity between studies: type of treatment
(exclusively trauma focused or not), risk of bias score, study
design and sample size. We observed no effect of type of treatment,
study design and sample size. Only a borderline significant effect of
bias score was observed. The effect of dissociation on treatment
outcome tended to be smaller in the higher-quality studies. No
less than one-third of the studies (33%) had a low study quality
score, however a post hoc analysis including only those studies
with a low or moderate risk of bias again revealed no moderating
effect of dissociation. We conclude that this meta-analysis provides
no evidence for the idea that dissociation specifically reduces the
effectiveness of trauma-focused treatment in those with PTSD.
Limitations
This study has some limitations. First, a meta-analysis can only be as
convincing as the quality of the individual studies. In most studies,
the effect size of dissociation is based on completer samples (n = 19),
thereby limiting the conclusions to those patients who complete
treatment. However, all included studies that reported on the
effect of dissociation on treatment drop-out found that dissociation
was not related to higher treatment drop-out.9,26,27,30,31,41,42 Cloitre
and colleagues (2012) even found that patients with high dissoci-
ation were less likely to drop-out from treatment.27 We observed
quite a few studies of less than optimal quality, however, results
were independent of study quality.
As we included several non-controlled clinical trials or cohort
studies, we evaluated whether the effect sizes of the included treat-
ments were comparable with previous meta-analyses of psychother-
apy for PTSD. The psychotherapies of the included studies showed
large within-participant effect sizes from pre- to post-treatment
(Cohen’s d or Hedges’ g) for treatment completers (mean 1.42)
and intention-to-treat samples (mean 1.39). These effect sizes are
comparable with those found in meta-analyses investigating the
effectiveness of psychotherapy for PTSD as such (and including
only randomised clinical trials44).
General limitations of the current studies in patients with PTSD
are a lack of long-term follow-up measurements and the use of
exclusion criteria (for example suicidality, psychosis or substance
misuse), which limits the generalisability of the results. We encour-
age future studies to use non-restrictive in- and exclusion criteria.45
Second, most (67% of) studies measured dissociation broadly with
the Dissociative Experience Scale, which includes depersonalisation,
derealisation, amnesia and absorption. Only a few studies measured
the dissociative subtype (depersonalisation and derealisation) spe-
cifically (n = 5). Furthermore, a recent study indicated that broad
and specific measures have a large overlap and high correlation.46
Future studies could focus on other instruments with a different
timing of dissociation, for example within-session (state)
dissociation.33
Thirdly, we exclusively focused on the effect of only one moder-
ator, that is dissociation, on treatment effects. This specific hypoth-













Fig. 3 Funnel plot with Pearson’s correlation coefficient between
dissociation and change in post-traumatic stress disorder
symptoms from pre- to post-treatment.
Table 3 Effect of dissociation on improvement in post-traumatic
stress disorder (PTSD) symptoms and moderation analysesa
n
Pearson’s
r 95% CI P
Overall outcome 21 0.04 −0.04 to 0.13 0.32
Moderation analyses
Trauma focused 8 0.06 −0.11 to 0.22 0.76b
Not trauma focused/
combination
16 0.02 −0.09 to 0.14
RCT 9 −0.03 −0.17 to 0.11 0.18b
No RCT 12 0.10 −0.02 to 0.21
Sample size 21 0.001 −0.001 to 0.002 0.38
Risk of bias score 21 0.03 −0.002 to 0.06 0.07
a. Positive correlation (Pearson’s correlation) indicates negative effect of dissociation on
PTSD improvement.
b. P-value indicates whether effect size of subgroups differ significantly.
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Possibly, a combination of patient characteristics (i.e. dissociation,
depressive symptoms and functional impairment) is more predict-
ive of treatment responsiveness.47 Future work may consider exam-
ining combinations of moderators to detect patients who do not
(fully) recover with psychotherapy and to detect differential treat-
ment responses.48 However, the sample sizes will need to be sub-
stantial and the risk of spurious or population-specific findings
increases if research is not hypothesis-driven. Finally, we did not
have the power to evaluate how moderators of the effect of dissoci-
ation interact. This could provide more insight into the effect of dis-
sociation under specific conditions.49
Interpretation
Despite these limitations, the strength of our meta-analysis is that it
is the first to systematically review the effect of dissociation on psy-
chotherapy outcome in patients with PTSD across different types of
psychotherapies. Psychotherapy for PTSD is generally effective but
there is room for improvement since about half of the patients still
meet criteria for PTSD after treatment.50 About half of clinicians
believe that any degree of dissociation is a contraindication for psy-
chotherapeutic treatment of PTSD.45,51 Importantly, the results of
our meta-analysis contrast this supposition. We found that pre-
treatment dissociation did not reduce the effectiveness of psycho-
therapy in patients with PTSD.
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